Correlation Between GlaxoSmithKline PLC and Aristotle Funds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Aristotle Funds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Aristotle Funds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Aristotle Funds Series, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Aristotle Funds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Aristotle Funds. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Aristotle Funds.

Diversification Opportunities for GlaxoSmithKline PLC and Aristotle Funds

-0.88
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Aristotle is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Aristotle Funds Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aristotle Funds Series and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Aristotle Funds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aristotle Funds Series has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Aristotle Funds go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Aristotle Funds

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Aristotle Funds. In addition to that, GlaxoSmithKline PLC is 1.5 times more volatile than Aristotle Funds Series. It trades about 0.0 of its total potential returns per unit of risk. Aristotle Funds Series is currently generating about 0.14 per unit of volatility. If you would invest  1,093  in Aristotle Funds Series on August 26, 2024 and sell it today you would earn a total of  376.00  from holding Aristotle Funds Series or generate 34.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Aristotle Funds Series

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Aristotle Funds Series 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aristotle Funds Series are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak essential indicators, Aristotle Funds may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Aristotle Funds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Aristotle Funds

The main advantage of trading using opposite GlaxoSmithKline PLC and Aristotle Funds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Aristotle Funds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aristotle Funds will offset losses from the drop in Aristotle Funds' long position.
The idea behind GlaxoSmithKline PLC ADR and Aristotle Funds Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences